Health Catalyst refrains from 2026 annual guidance as new CEO launches operational overhaul and strategic review (NASDAQ:HCAT)
Core Insights - Health Catalyst has refrained from providing annual guidance for 2026 as the new CEO initiates an operational overhaul and strategic review [2] Management View - CEO Benjamin Albert addressed his recent appointment, noting he took over the role following the departure of Dan Burton from both the CEO position and the Board of Directors [2]